A detailed history of Larson Financial Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Larson Financial Group LLC holds 14,844 shares of LLY stock, worth $11.4 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
14,844
Previous 15,144 1.98%
Holding current value
$11.4 Million
Previous $13.7 Million 4.09%
% of portfolio
0.75%
Previous 0.95%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $231,642 - $288,006
-300 Reduced 1.98%
14,844 $13.2 Million
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $4.18 Million - $5.24 Million
5,761 Added 61.4%
15,144 $13.7 Million
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $100,674 - $134,687
170 Added 1.85%
9,383 $7.3 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $139,700 - $164,688
266 Added 2.97%
9,213 $5.37 Million
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $2.19 Million - $3.01 Million
5,027 Added 128.24%
8,947 $4.81 Million
Q2 2023

Aug 03, 2023

SELL
$350.74 - $468.98 $56,819 - $75,974
-162 Reduced 3.97%
3,920 $1.84 Million
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $30,752 - $36,117
99 Added 2.49%
4,082 $1.4 Million
Q4 2022

Feb 03, 2023

BUY
$321.55 - $374.67 $643 - $749
2 Added 0.05%
3,983 $1.46 Million
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $55,145 - $62,843
186 Added 4.9%
3,981 $1.29 Million
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $208,211 - $244,470
747 Added 24.51%
3,795 $1.23 Million
Q1 2022

May 05, 2022

BUY
$234.69 - $291.66 $16,193 - $20,124
69 Added 2.32%
3,048 $873,000
Q4 2021

Feb 03, 2022

BUY
$224.85 - $279.04 $355,712 - $441,441
1,582 Added 113.24%
2,979 $823,000
Q3 2021

Nov 04, 2021

SELL
$221.6 - $272.71 $43,876 - $53,996
-198 Reduced 12.41%
1,397 $323,000
Q2 2021

Aug 10, 2021

BUY
$180.55 - $233.54 $361 - $467
2 Added 0.13%
1,595 $366,000
Q1 2021

May 06, 2021

BUY
$164.32 - $212.72 $89,718 - $116,145
546 Added 52.15%
1,593 $298,000
Q4 2020

Jan 14, 2021

BUY
$130.46 - $172.63 $130 - $172
1 Added 0.1%
1,047 $177,000
Q4 2019

Jan 10, 2020

SELL
$106.92 - $132.43 $17,214 - $21,321
-161 Reduced 13.34%
1,046 $138,000
Q3 2019

Oct 11, 2019

BUY
$106.79 - $116.16 $81,053 - $88,165
759 Added 169.42%
1,207 $135,000
Q1 2019

Apr 05, 2019

BUY
$111.31 - $131.02 $22,262 - $26,204
200 Added 80.65%
448 $58,000
Q4 2018

Feb 07, 2019

BUY
$105.9 - $118.64 $26,263 - $29,422
248 New
248 $29,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.